A study of 219 cognitively normal adults enrolled in longitudinal aging studies indicated that 51.9% wanted Apolipoprotein E (APOE) genotype, despite the fact that Alzheimer’s disease is non-actionable [7]. The gene discussed is APOE; the disease is early-onset autosomal dominant Alzheimer disease.